Integrating CD4(+) T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model

Head and neck squamous cell carcinomas (HNSCC) are well suited for cancer vaccination strategies. In addition to tumor-associated antigens (TAAs) and endogenous retrovirus (ERV) encoded proteins, HNSCCs have a relatively high tumor mutational burden encoding potential neoepitopes. Peptide vaccine ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Hirofumi, Xu, Na, Saito, Shin, Zhou, Liye, Ozgenc, Ibrahim, Webb, Jason, Fu, Cong, Zolkind, Paul, Egloff, Ann Marie, Uppaluri, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366550/
https://www.ncbi.nlm.nih.gov/pubmed/34408919
http://dx.doi.org/10.1080/2162402X.2021.1958589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366550/
https://www.ncbi.nlm.nih.gov/pubmed/34408919
http://dx.doi.org/10.1080/2162402X.2021.1958589

Ejemplares similares